Seres Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: -35.78

Seres Therapeutics, Inc. Interest Coverage Ratio is -35.78 for the Trailing 12 Months (TTM) ending March 31, 2025, a 751.25% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Seres Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was -4.20.
  • Seres Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -27.09, a -23.79% change year over year.
  • Seres Therapeutics, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -35.54, a -32.74% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)